1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
  4. > Active Transdermal Drug Delivery to 2018

Active Transdermal Drug Delivery to 2018

  • May 2014
  • -
  • Greystone Research Associates

Products, Players, Markets & Forecasts

The administration of therapeutic drugs via e advantages of transdermal drug delivery for improving patient compliance, particularly for the treatment of chronic conditions, are well known. But growth of transdermal delivery has been restricted by the need to limit candidate drugs to molecules small enough to effectively pass through the stratum corneum, a limitation that excludes passive transdermal patches as a viable option for the growing number of protein and peptide therapeutic compounds that will represent an increasing share of future NCEs. New technologies that employ energy or mechanical designs to affect drug transport through the skin are expanding the type and number of drug candidates that are viable for transdermal delivery. Evolving active transdermal systems will be well-positioned to address a significant segment of the large –molecule biological drugs expected to emerge from the convergence of automated discovery and genome mapping. As designs shrink in size and become more patient-friendly, opportunities for active transdermal delivery will increase.


- What are the key segments and technologies that comprise the market for active transdermal drug delivery?
- What are the major therapeutic demand drivers for active transdermal drug products?
- What are the design issues and market factors that influence product commercialization?
- What is the market today and what will it look like in 2018?
- Who are the companies behind the current generation of active transdermal delivery and what are their business models?
- What is the role of pharma-device alliances and design partnerships?
- What is the impact of economic, technology, and regulatory factors?

Table Of Contents

Active Transdermal Drug Delivery to 2018
Executive Summary

Active Transdermal Drug Delivery Market Dynamics

Active Transdermal Technology Overview
Market Drivers for Transdermal Delivery
Excipients and Penetration Enhancers
Competitive Landscape
Factors Limiting Growth

Active Transdermal Technologies

Electrical Current
Mechanical Arrays
Radio Frequency

Active Transdermal Design Factors

Drug Formulation Factors
Proprietary Delivery vs. 3rd Party Patches
Dosing and Rate Factors

Commercial Active Transdermal Platforms - Assessment and Prospects


Active Transdermal Delivery - Market Analysis and Forecasts

Nonviral Gene Delivery
Metabolic Diseases
Pain Management
Physical Medicine

Market Factors

FDA Regulations
Clinical Trial Process
Rx-to-OTC Switching
Shifting Patient Demographics

Market Participant Profiles

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Transdermal Drug Delivery Systems Market Report 2016

Global Transdermal Drug Delivery Systems Market Report 2016

  • $ 2 850
  • Industry report
  • August 2016
  • by 9Dimen Research

2016 Global Transdermal Drug Delivery Systems Report is a professional and in-depth research report on the world's major regional market conditions of the Transdermal Drug Delivery Systems industry, focusing ...

Medical Device Leader Series: Top Needle-Free Injection Device Developers, Manufacturers and Marketers in 2016

Medical Device Leader Series: Top Needle-Free Injection Device Developers, Manufacturers and Marketers in 2016

  • $ 2 508
  • Industry report
  • June 2016
  • by Visiongain

Report Details Needle-Free Drug Injecting Technologies – Discover Leading Companies’ Products, Developments, Results and Potentials What does the future hold for producers of needle-free injection ...

Microneedle Diagnostics

Microneedle Diagnostics

  • $ 3 850
  • Industry report
  • May 2016
  • by Greystone Research Associates

Microneedle technology is attaining commercial viability at a time when healthcare providers are faced with new challenges as they assess ways to incorporate companion diagnostics into their practice areas. ...

Connected Skin Patches

February 2016 $ 1 850


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.